Literature DB >> 7994921

Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria.

C Wenisch1, B Parschalk, E Narzt, S Looareesuwan, W Graninger.   

Abstract

Serum levels of interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) were determined in 37 patients with acute Plasmodium falciparum malaria in Bangkok, Thailand. Serum levels of IL-10 and IFN-gamma were markedly elevated in patients with malaria prior to treatment (717 +/- 260 pg/ml versus 2.2 +/- 1.3 pg/ml in healthy controls; 123 +/- 71 pg/ml versus 29 +/- 9 pg/ml, respectively; mean +/- SD). Serum levels of IFN-gamma and IL-10 dropped significantly during treatment and were normal 14 and 21 days, respectively, after treatment was started. Prior to therapy a correlation between serum levels of IFN-gamma and IL-10 existed (r = 0.563). These results suggest that stimulatory and inhibitory cytokines for macrophage activation and/or antibody production (i.e., TH1- and TH2-type immunoreaction, respectively) are coexpressed during acute P. falciparum infection and stress the multifactorial network between host and parasite in malaria immunology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7994921     DOI: 10.1006/clin.1995.1017

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  29 in total

1.  West African donors have high percentages of activated cytokine producing T cells that are prone to apoptosis.

Authors:  K Kemp; B D Akanmori; L Hviid
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

2.  Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria.

Authors:  K Kemp; B D Akanmori; V Adabayeri; B Q Goka; J A L Kurtzhals; C Behr; L Hviid
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 3.  Effect of malaria components on blood mononuclear cells involved in immune response.

Authors:  Chuchard Punsawad
Journal:  Asian Pac J Trop Biomed       Date:  2013-09

4.  Interleukin-10 modulates susceptibility in experimental cerebral malaria.

Authors:  S Kossodo; C Monso; P Juillard; T Velu; M Goldman; G E Grau
Journal:  Immunology       Date:  1997-08       Impact factor: 7.397

5.  Interferon-gamma administration does not affect human thyroid hormone metabolism in the post-surgical euthyroid sick syndrome.

Authors:  J de Metz; J A Romijn; D J Gouma; I J M ten Berge; O R C Busch; E Endert; H P Sauerwein
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

6.  Relationship between serum 3,5,3'-triiodothyronine and serum interleukin-8, interleukin-10 or interferon gamma in patients with nonthyroidal illness.

Authors:  A Boelen; M C Schiphorst; W M Wiersinga
Journal:  J Endocrinol Invest       Date:  1996 Jul-Aug       Impact factor: 4.256

7.  Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.

Authors:  M S Rhee; B D Akanmori; M Waterfall; E M Riley
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

Review 8.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women.

Authors:  Nana O Wilson; Tameka Bythwood; Wesley Solomon; Pauline Jolly; Nelly Yatich; Yi Jiang; Faisal Shuaib; Andrew A Adjei; Winston Anderson; Jonathan K Stiles
Journal:  Infect Dis Obstet Gynecol       Date:  2010-07-12

10.  Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria.

Authors:  Gabriela Minigo; Tonia Woodberry; Kim A Piera; Ervi Salwati; Emiliana Tjitra; Enny Kenangalem; Ric N Price; Christian R Engwerda; Nicholas M Anstey; Magdalena Plebanski
Journal:  PLoS Pathog       Date:  2009-04-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.